Page last updated: 2024-08-26

phenylacetylglutamine and Cardiovascular Diseases

phenylacetylglutamine has been researched along with Cardiovascular Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Anderson, JT; Battle, S; Buffa, JA; DiDonato, JA; Dwidar, M; Fischbach, MA; Fu, X; Funabashi, M; Gogonea, V; Hajjar, AM; Hazen, SL; Keranahalli, P; Li, XS; Nemet, I; Romano, KA; Sangwan, N; Tittle, AN; Wang, Z; Zhu, Y1
Cajka, T; DiDonato, JA; Fiehn, O; Fischbach, MA; Funabashi, M; Gupta, N; Hazen, SL; Li, L; Mohan, ML; Naga Prasad, SV; Nemet, I; Ramer-Tait, AE; Rey, FE; Romano, KA; Saha, PP; Skye, SM; Tang, WHW; Wu, Y; Zhu, W1
Hazen, SL; Weeks, TL; Witkowski, M1
Banerjee, T; Coresh, J; Hostetter, TH; Hwang, S; Melamed, ML; Meyer, TW; Plummer, NS; Powe, NR; Shafi, T; Sirich, TL1
Banerjee, T; Coresh, J; Hostetter, TH; Hwang, S; Melamed, ML; Meyer, TW; Parekh, RS; Powe, NR; Shafi, T1
Augustijns, P; Claes, K; de Loor, H; Evenepoel, P; Kuypers, D; Meijers, B; Poesen, R1

Reviews

1 review(s) available for phenylacetylglutamine and Cardiovascular Diseases

ArticleYear
Gut Microbiota and Cardiovascular Disease.
    Circulation research, 2020, 07-31, Volume: 127, Issue:4

    Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cardiovascular Diseases; Carnitine; Choline; Disease Models, Animal; Fatty Acids, Volatile; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Glutamine; Host Microbial Interactions; Humans; Methylamines; Mice; Mice, Inbred C57BL; Signal Transduction; Thrombosis; Vasculitis

2020

Trials

1 trial(s) available for phenylacetylglutamine and Cardiovascular Diseases

ArticleYear
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Kidney international, 2017, Volume: 92, Issue:6

    Topics: Adult; Aged; Cardiovascular Diseases; Cresols; Female; Glutamine; Hippurates; Humans; Indican; Kidney Failure, Chronic; Longitudinal Studies; Male; Middle Aged; Renal Dialysis; Risk Factors; Serum Albumin; Sulfuric Acid Esters; Uremia

2017

Other Studies

4 other study(ies) available for phenylacetylglutamine and Cardiovascular Diseases

ArticleYear
Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease.
    Cell host & microbe, 2023, 01-11, Volume: 31, Issue:1

    Topics: Animals; Cardiovascular Diseases; Gastrointestinal Microbiome; Glutamine; Mice

2023
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.
    Cell, 2020, 03-05, Volume: 180, Issue:5

    Topics: Animals; Arteries; Bacterial Proteins; Blood Platelets; Cardiovascular Diseases; Death, Sudden, Cardiac; Gastrointestinal Microbiome; Glutamine; Humans; Male; Metabolome; Metabolomics; Mice; Myocardial Infarction; Platelet Activation; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Risk Factors; Stroke; Thrombosis

2020
Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Cause of Death; Cresols; Female; Glutamine; Hippurates; Humans; Indican; Kidney Failure, Chronic; Male; Middle Aged; Morbidity; Mortality; Patient Outcome Assessment; Renal Dialysis; Sulfuric Acid Esters; United States

2015
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.
    Journal of the American Society of Nephrology : JASN, 2016, Volume: 27, Issue:11

    Topics: Adult; Aged; Cardiovascular Diseases; Female; Glutamine; Humans; Male; Microbiota; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic

2016